Design of CD40 agonists and their use in growing B cells for cancer immunotherapy. - Wikidata - wikimedia - TriplyDB

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

http://www.wikidata.org/entity/Q37273700

about

Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs.Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancer.Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.

P2860

Q35777971-4A38A402-DBCE-4326-9AAE-D1C61CF2E524 Q37158481-E0224CF8-6472-4C24-AD96-12B3D836697F Q37547365-EE71A4D3-CD83-4C69-A582-F75B277CBAF2 Q38094625-B856F55B-CA76-411F-9680-06CEA3215506 Q38120535-778DBA4B-9EFF-4A90-BB2A-C8423C0ACDD2 Q38201655-CE95A021-ECB3-4346-8421-FBB33DD9F7AC Q41855863-BDF8E4BA-A501-4A00-8134-8BDB451445BE Q48215037-666F0DAE-564F-428B-AC64-E628842C9DEE

P2860

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

http://www.wikidata.org/entity/Q37273700

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

@en

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

@nl

type

label

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

@en

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

@nl

prefLabel

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

@en

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

@nl

P1433

Q37273700-EB07AB03-FE16-41C0-8F0C-F037113C6427

P1476

Q37273700-DF1514EC-EAAD-4272-AF6F-E02424FC1337

P2093

Q37273700-AA13B96F-13CD-4B09-A820-E9C25ACDD4C0

Q37273700-B720075C-FFAC-4BE2-8A4B-67107FE75B91

Q37273700-BB3862E4-B97D-49CF-8729-0867225C386B

P2860

Q37273700-03C5B8F2-FB03-458E-9596-CD56626A8FAC

Q37273700-0680C75F-6FE0-4378-B430-BD5FB32CBC84

Q37273700-080B19FB-EAB0-4609-9267-324F608BC9DE

Q37273700-16E73992-7D80-45C4-804E-750F3B309C42

Q37273700-16FB07CD-9646-4BDE-8578-29DBA4090365

Q37273700-1CEF88B9-2805-4F94-969E-0FB5DBEB20FD

Q37273700-21A60B9B-A653-4BC1-8508-F69680CD137F

Q37273700-25BE71BF-2922-4807-B88B-76FF873F42AD

Q37273700-2A8B9528-A2CF-4814-A0C4-54C33821A001

Q37273700-2C93E88E-117B-41A4-ADE5-4BE4E2FF09B4

P304

Q37273700-0473F7F8-F89B-49CA-8776-90CE3B04DE5A

P31

Q37273700-4EC19605-D12A-440A-97A9-0E55704A02BF

P356

Q37273700-4144F177-AA19-4EED-9435-5EE296CF8795

P433

Q37273700-C419EA3A-7686-48B6-9865-5D907CA747FF

P478

Q37273700-0EE610F6-3FFD-4607-8ECB-76F37C23A8A3

P577

Q37273700-0DFCAC4C-BE06-475C-A00E-71130A18924E

P698

Q37273700-4E4AA5AB-2054-4B2C-9CA5-7613C112615F

P921

Q37273700-A8B51387-87F4-4530-8DEB-2747D86BF0BE

P932

Q37273700-103BFFCC-CA71-4D1F-8015-F32EFD5D6621

P356

08830185.2012.703272

P1433

International Reviews of Immunology

P1476

Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.

@en

P2093

Geoffrey W Stone

http://www.w3.org/2001/XMLSchema#string

Mariusz Stempniak

http://www.w3.org/2001/XMLSchema#string

Richard S Kornbluth

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of CRAF1, a relative of TRAF, in CD40 signaling

Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help

A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

Biophysical characterization of a soluble CD40 ligand (CD154) coiled-coil trimer: evidence of a reversible acid-denatured molten globule.

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells.

CD40-activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non-Hodgkin's lymphoma

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

P304

279-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08830185.2012.703272

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22804572

http://www.w3.org/2001/XMLSchema#string

P921

P932

3815466

http://www.w3.org/2001/XMLSchema#string